Premium
Treatment of Angioblastoma with Recombinant Interferon‐α 2
Author(s) -
Park Kyoung Chan,
Ahn Phil Soo,
Lee Vong Suk,
Kim Kyu Han,
Cho Kwang Hyun
Publication year - 1995
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/j.1525-1470.1995.tb00150.x
Subject(s) - medicine , recombinant dna , interferon , sarcoma , alpha interferon , interferon alfa , dermatology , immunology , pathology , gene , biochemistry , chemistry
interferon‐α 2 has been used successfully to treat anglomatous lesions such as Kaposi sarcoma and life‐threatening hemangiomas, possibly by its antlangiogenetic activity. We report the successful use of this agent in a child with an angloblastoma of the right leg.